The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.

Cibula, David; Dostálek, Lukás; Jarkovsky, Jiri; Mom, Constantijne H; Lopez, Aldo; Falconer, Henrik; Fagotti, Anna; Ayhan, Ali; Kim, Sarah H; Isla Ortiz, David; Klat, Jaroslav; Obermair, Andreas; Landoni, Fabio; Rodriguez, Juliana; Manchanda, Ranjit; Kostun, Jan; Dos Reis, Ricardo; Meydanli, Mehmet M; Odetto, Diego; Laky, Rene; Zapardiel, Ignacio; Weinberger, Vit; Benesová, Klára; Borcinová, Martina; Pari, Darwin; Salehi, Sahar; Bizzarri, Nicolò; Akilli, Huseyin; Abu-Rustum, Nadeem R; Salcedo-Hernández, Rosa A; Javurková, Veronika; Sláma, Jirí; van Lonkhuijzen, Luc R C W

The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.

Cibula, David; Dostálek, Lukás; Jarkovsky, Jiri; Mom, Constantijne H; Lopez, Aldo; Falconer, Henrik; Fagotti, Anna; Ayhan, Ali; Kim, Sarah H; Isla Ortiz, David; Klat, Jaroslav; Obermair, Andreas; Landoni, Fabio; Rodriguez, Juliana; Manchanda, Ranjit; Kostun, Jan; Dos Reis, Ricardo; Meydanli, Mehmet M; Odetto, Diego; Laky, Rene; Zapardiel, Ignacio; Weinberger, Vit; Benesová, Klára; Borcinová, Martina; Pari, Darwin; Salehi, Sahar; Bizzarri, Nicolò; Akilli, Huseyin; Abu-Rustum, Nadeem R; Salcedo-Hernández, Rosa A; Javurková, Veronika; Sláma, Jirí; van Lonkhuijzen, Luc R C W.

Afiliação

Cibula D; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital (Central and Eastern European Gynecologic Oncology Group, CEEGOG), Prague, Czech Republic. Electronic address: dc@davidcibula.cz.
Dostálek L; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital (Central and Eastern European Gynecologic Oncology Group, CEEGOG), Prague, Czech Republic.
Jarkovsky J; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Mom CH; Amsterdam Medical Center, Amsterdam, the Netherlands.
Lopez A; Department of Gynecological Surgery, National Institute of Neoplastic Diseases, Lima, Peru.
Falconer H; Department of Pelvic Cancer, Karolinska University Hospital and Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Fagotti A; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la Salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
Ayhan A; Baskent University School of Medicine, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Ankara, Turkey.
Kim SH; Memorial Sloan Kettering Cancer Center, USA.
Isla Ortiz D; Gynecology Oncology Center, National Institute of Cancerology Mexico, Mexico.
Klat J; Department of Obstetrics and Gynecology, Faculty of Medicine, University Hospital and University of Ostrava, Ostrava, Czech Republic.
Obermair A; Queensland Centre for Gynaecological Cancer, The University of Queensland, Australia.
Landoni F; University of Milano-Bicocca, Department of Obstetrics and Gynecology, Gynaecologic Oncology Surgical Unit, ASST-Monza, San Gerardo Hospital, Monza, Italy.
Rodriguez J; Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.
Manchanda R; Wolfson Institute of Preventive Medicine, Barts Cancer Centre, Queen Mary University of London, & Barts Health NHS Trust, London, UK.
Kostun J; Department of Gynaecology and Obstetrics, University Hospital Pilsen, Charles University, Prague, Czech Republic.
Dos Reis R; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Meydanli MM; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health and Research Hospital, University of Health Sciences, Ankara, Turkey.
Odetto D; Department of Gynecologic Oncology, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano, Buenos Aires, Argentina.
Laky R; Gynecology, Medical University of Graz, Graz, Austria.
Zapardiel I; Gynecologic Oncology Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain.
Weinberger V; University Hospital Brno, Medical Faculty of Masaryk University, Czech Republic.
Benesová K; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Borcinová M; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital (Central and Eastern European Gynecologic Oncology Group, CEEGOG), Prague, Czech Republic.
Pari D; Department of Gynecological Surgery, National Institute of Neoplastic Diseases, Lima, Peru.
Salehi S; Department of Pelvic Cancer, Karolinska University Hospital and Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Bizzarri N; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la Salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
Akilli H; Baskent University School of Medicine, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Ankara, Turkey.
Abu-Rustum NR; Memorial Sloan Kettering Cancer Center, USA.
Salcedo-Hernández RA; Gynecology Oncology Center, National Institute of Cancerology Mexico, Mexico.
Javurková V; Department of Obstetrics and Gynecology, Faculty of Medicine, University Hospital and University of Ostrava, Ostrava, Czech Republic.
Sláma J; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital (Central and Eastern European Gynecologic Oncology Group, CEEGOG), Prague, Czech Republic.
van Lonkhuijzen LRCW; Amsterdam Medical Center, Amsterdam, the Netherlands.